Indaptus Registers 58.9M Shares for Resale — 44% of Outstanding Now Tradable

summarizeSummary

Indaptus filed a prospectus supplement making 58.9 million shares — 44% of shares outstanding — eligible for resale by selling stockholders, including 38.9 million shares held by Sino Lion Ventures Limited. The company receives no proceeds.

check_boxKey Events · Financing and Capital Events · INDP

• 58.9M Shares Registered for Resale

  Prospectus supplement activates resale registration for 58,895,000 shares, representing approximately 44.2% of the 133,242,324 shares outstanding as of the prospectus date.

• Sino Lion Ventures Holds 29.19% Stake

  Sino Lion Ventures Limited is the largest selling stockholder with 38,895,000 shares (29.19% of outstanding), acquired via the March 2026 change of control from David Lazar.

• Company Receives No Proceeds

  All net proceeds from any sales go to the selling stockholders; Indaptus receives nothing and bears the registration expenses.

• Overhang on Distressed Company

  The resale registration comes amid a going-concern warning, no active clinical programs, and a stock price near $1.10, amplifying the potential selling pressure.

auto_awesomeAnalysis · INDP · Life Sciences

This prospectus supplement activates the resale registration for 58,895,000 shares — approximately 44.2% of the 133,242,324 shares outstanding — held by selling stockholders. The company receives no proceeds; all sales benefit the selling stockholders. The largest holder, Sino Lion Ventures Limited, can now sell 38,895,000 shares (29.19% of outstanding). This creates a substantial overhang on the stock, especially given the company's going-concern warning, no active clinical programs, and a stock price near $1.10. The registration does not force sales, but it removes the last barrier to a large-scale exit by the controlling shareholders who acquired their stakes in the March 2026 change of control.